{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:22:48Z","timestamp":1794338568414,"version":"4.9.0"},"publisher-location":"Berlin\/Heidelberg","reference-count":62,"publisher":"Springer-Verlag","isbn-type":[{"value":"3540272615","type":"print"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/3-540-27262-3_19","type":"book-chapter","created":{"date-parts":[[2006,2,3]],"date-time":"2006-02-03T20:13:48Z","timestamp":1138997628000},"page":"375-393","source":"Crossref","is-referenced-by-count":10,"title":["RNA Aptamers as Potential Pharmaceuticals Against Infections with African Trypanosomes"],"prefix":"10.1007","author":[{"given":"H.U.","family":"G\u00f6ringer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Homann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zacharias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"19_CR1","first-page":"60","volume":"209","author":"S. Agrawal","year":"1997","unstructured":"Agrawal S, Zhang R (1997) Pharmacokinetics of oligonucleotides. Ciba Found Symp 209:60\u201375","journal-title":"Ciba Found Symp"},{"key":"19_CR2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1126\/science.300.5618.430","volume":"300","author":"S. Andreopoulos","year":"2003","unstructured":"Andreopoulos S (2003) Developing drugs for parasitic diseases. Science 300:430\u2013431","journal-title":"Science"},{"key":"19_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/362603a0","volume":"362","author":"M.L. Blum","year":"1993","unstructured":"Blum, ML, Down JA, Gurnett AM, Carrington M, Turner MJ, Wiley DC (1993) A structural motif in the variant surface glycoproteins of Trypanosoma brucei. Nature 362:603\u2013609","journal-title":"Nature"},{"key":"19_CR4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1021\/bc970082p","volume":"8","author":"G.M. Bonora","year":"1997","unstructured":"Bonora GM, Ivanova E, Zarytova V, Burcovich B, Veronese FM (1997) Synthesis and characterization of high-molecular mass polyethylene glycol-conjugated oligonucleotides. Bioconjug Chem 8:793\u2013797","journal-title":"Bioconjug Chem"},{"key":"19_CR5","first-page":"5","volume":"74","author":"E.N. Brody","year":"2000","unstructured":"Brody EN, Gold L (2000) Aptamers as therapeutic and diagnostic agents. J Biotechnol 74:5\u201313","journal-title":"J Biotechnol"},{"key":"19_CR6","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S1359-6446(02)02522-9","volume":"7","author":"P. Burgstaller","year":"2002","unstructured":"Burgstaller P, Girod A, Blind M (2002) Aptamers as tools for target prioritization and lead identification. Drug Discov Today 7:1221\u20131228","journal-title":"Drug Discov Today"},{"key":"19_CR7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bmb\/62.1.139","volume":"62","author":"A. Capron","year":"2002","unstructured":"Capron A, Capron M, Riveau G (2002) Vaccine development against schistosomiasis from concepts to clinical trials. Br Med Bull 62:139\u2013148","journal-title":"Br Med Bull"},{"key":"19_CR8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1126\/science.3863253","volume":"230","author":"M.H. Caruthers","year":"1985","unstructured":"Caruthers MH (1985) Gene synthesis machines: DNA chemistry and its uses. Science 230:281\u2013285","journal-title":"Science"},{"key":"19_CR9","unstructured":"Cecchelli R, Dehouck B, Descamp L, Fenart L, Bu\u00e9e-Scherrer V, Duhem C, Torpier G, Dehouck MP (2000) In vitro models of the blood-brain barrier and their use in drug development. In: The blood-brain barrier and drug delivery to the CNS. Eds. Begley DJ, Bradbury MW, Kreuter J. pp 65\u201375"},{"key":"19_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S0959-440X(98)80059-6","volume":"8","author":"G.L. Conn","year":"1998","unstructured":"Conn GL, Draper DE (1998) RNA structure. Curr Opin Struct Biol 8:278\u2013285","journal-title":"Curr Opin Struct Biol"},{"key":"19_CR11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1017\/S003118200004717X","volume":"71","author":"G.A.M. Cross","year":"1975","unstructured":"Cross GAM (1975) Identification, purification and properties of clone-specific glycoprotein antigens constituting the surface coat of Trypanosoma brucei. Parasitology 71:393\u2013417","journal-title":"Parasitology"},{"key":"19_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1590\/S0074-02762002000500002","volume":"97","author":"J.C. Dias","year":"2002","unstructured":"Dias JC, Silveira AC, Schofield CJ (2002) The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz 97:603\u2013612","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"19_CR13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0001-706X(02)00237-1","volume":"85","author":"J.E. Donelson","year":"2003","unstructured":"Donelson JE (2003) Antigenic variation and the African trypanosome genome. Acta Trop 85:391\u2013404","journal-title":"Acta Trop"},{"key":"19_CR14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1146\/annurev.bi.64.070195.004201","volume":"64","author":"B.E. Eaton","year":"1995","unstructured":"Eaton BE, Pieken WA (1995) Ribonucleosides and RNA. Annu Rev Biochem 64:837\u2013863","journal-title":"Annu Rev Biochem"},{"key":"19_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0168-3659(00)00316-3","volume":"69","author":"M.E. Eccleston","year":"2000","unstructured":"Eccleston ME, Kuiper M, Gilchrist FM, Slater NK (2000) pH-responsive pseudo-peptides for cell membrane disruption. J Control Release 69:297\u2013307","journal-title":"J Control Release"},{"key":"19_CR16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/346818a0","volume":"346","author":"A.D. Ellington","year":"1990","unstructured":"Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818\u2013822","journal-title":"Nature"},{"key":"19_CR17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00018-002-8472-0","volume":"59","author":"B. Enanga","year":"2002","unstructured":"Enanga B, Burchmore RJS, Stewart ML, Barrett MP (2002) Sleeping sickness and the brain. Cell Mol Life Sci 59:845\u2013858","journal-title":"Cell Mol Life Sci"},{"key":"19_CR18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.pt.2003.09.002","volume":"19","author":"A.H. Fairlamb","year":"2003","unstructured":"Fairlamb AH (2003) Chemotherapy of human African trypanosomiasis: current and future prospects. Trends Parasitol 19:488\u2013494","journal-title":"Trends Parasitol"},{"key":"19_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nrd1677","volume":"4","author":"S.L. Fine","year":"2005","unstructured":"Fine SL, Martin DF, Kirkpatrick P (2005) Pegaptanib sodium. Nat Rev Drug Discov 4:187\u20138","journal-title":"Nat Rev Drug Discov"},{"key":"19_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0006-8993(98)01282-7","volume":"818","author":"H. Franke","year":"1999","unstructured":"Franke H, Galla HJ, Beuckmann CT (1999). An improved low-permeability in vitro model of the blood-brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol. Brain Res 818:65\u201371","journal-title":"Brain Res"},{"key":"19_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S1385-299X(00)00020-9","volume":"5","author":"H. Franke","year":"2000","unstructured":"Franke H, Galla HJ, Beuckmann CT (2000). Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro. Brain Res Protocols 5:248\u2013256","journal-title":"Brain Res Protocols"},{"key":"19_CR22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-2836(05)80066-X","volume":"216","author":"D. Freymann","year":"1990","unstructured":"Freymann D, Down J, Carrington M, Roditi I, Turner M, Wiley D. (1990) 2.9 \u00c5 resolution structure of the N-terminal domain of a variant surface glycoprotein from Trypanosoma brucei. J Mol Biol 216:141\u2013460","journal-title":"J Mol Biol"},{"key":"19_CR23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0076-6879(96)67019-0","volume":"267","author":"T. Fitzwater","year":"1996","unstructured":"Fitzwater T, Polisky B (1996). A SELEX primer. Methods Enzymol 267:275\u2013301","journal-title":"Methods Enzymol"},{"key":"19_CR24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0928-0987(00)00123-8","volume":"12","author":"P.J. Gaillard","year":"2001","unstructured":"Gaillard PJ, Voorwinden LH, Nielsen JL, Ivanov A, Atsumi R, Engman H, Ringbom C, de Boer AG, Breimer DD (2001). Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur J Pharm Sci 12:215\u2013222","journal-title":"Eur J Pharm Sci"},{"key":"19_CR25","doi-asserted-by":"crossref","first-page":"13581","DOI":"10.1074\/jbc.270.23.13581","volume":"270","author":"L. Gold","year":"1995","unstructured":"Gold L (1995) Oligonucleotides as research, diagnostic, and therapeutic agents. J Biol Chem 270:13581\u201313584","journal-title":"J Biol Chem"},{"key":"19_CR26","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1056\/NEJMoa042760","volume":"351","author":"E.S. Gragoudas","year":"2004","unstructured":"Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351:2805\u20132816","journal-title":"N Engl J Med"},{"key":"19_CR27","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2144\/01305dd02","volume":"30","author":"L.S. Green","year":"2001","unstructured":"Green LS, Bell C, Janjic N (2001) Aptamers as reagents for high-throughput screening. Biotechniques 30:1094\u20131110","journal-title":"Biotechniques"},{"key":"19_CR28","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1007\/s11095-004-7676-4","volume":"21","author":"J.M. Healy","year":"2004","unstructured":"Healy JM, Lewis SD, Kurz M, Boomer RM, Thompson KM, Wilson C, McCauley TG (2004) Pharmacokinetics and biodistribution of novel aptamer compositions. Pharm Res 21:2234\u20132246","journal-title":"Pharm Res"},{"key":"19_CR29","first-page":"15","volume":"74","author":"J. Hesselberth","year":"2000","unstructured":"Hesselberth J, Robertson MP, Jhaveri S, Ellington AD (2000) In vitro selection of nucleic acids for diagnostic applications. J Biotechnol 74:15\u201325","journal-title":"J Biotechnol"},{"key":"19_CR30","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1093\/nar\/27.9.2006","volume":"27","author":"M. Homann","year":"1999","unstructured":"Homann M, G\u00f6ringer HU (1999) Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucl Acids Res 27:2006\u20132014","journal-title":"Nucl Acids Res"},{"key":"19_CR31","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/S0968-0896(01)00032-3","volume":"9","author":"M. Homann","year":"2001","unstructured":"Homann M, G\u00f6ringer HU (2001) Uptake and intracellular transport of RNA aptamers in African trypanosomes suggest therapeutic \u201cpiggy-back\u201d approach. Bioorg Med Chem 9:2571\u20132580","journal-title":"Bioorg Med Chem"},{"key":"19_CR32","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/clinchem\/45.9.1628","volume":"45","author":"S.D. Jayasena","year":"1999","unstructured":"Jayasena SD (1999) Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 45:1628\u20131650","journal-title":"Clin Chem"},{"key":"19_CR33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1042\/bj1780689","volume":"178","author":"J.G. Johnson","year":"1979","unstructured":"Johnson JG, Cross GA (1979) Selective cleavage of variant surface glycoproteins from Trypanosoma brucei. Biochem 178:689\u2013697","journal-title":"Biochem"},{"key":"19_CR34","first-page":"723","volume":"57","author":"A. Kaiser","year":"2002","unstructured":"Kaiser A, Gottwald A, Wiersch C, Maier W, Seitz HM (2002) The necessity to develop drugs against parasitic diseases. Pharmazie 57:723\u2013728","journal-title":"Pharmazie"},{"key":"19_CR35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/CMR.8.3.427","volume":"8","author":"M. Khaw","year":"1995","unstructured":"Khaw M, Panosian CB (1995) Human antiprotozoal therapy: past, present, and future. Clin Microbiol Rev 8:427\u2013439","journal-title":"Clin Microbiol Rev"},{"key":"19_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nrmicro848","volume":"2","author":"D. Kioy","year":"2004","unstructured":"Kioy D, Jannin J, Mattock N (2004) Human African trypanosomiasis. Nat Rev Microbiol 2:186\u2013187","journal-title":"Nat Rev Microbiol"},{"key":"19_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S1367-5931(02)00326-5","volume":"6","author":"K.S. Lam","year":"2002","unstructured":"Lam KS, Renil M (2002) From combinatorial chemistry to chemical microarray. Curr Opin Chem Biol 6:353\u2013358","journal-title":"Curr Opin Chem Biol"},{"key":"19_CR38","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1021\/bi982515x","volume":"38","author":"L.L. Lebruska","year":"1999","unstructured":"Lebruska LL, Maher LJ 3rd (1999) Selection and characterization of an RNA decoy for transcription factor NF-kappa B. Biochemistry 38:3168\u20133174","journal-title":"Biochemistry"},{"key":"19_CR39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1471-4922(01)02120-1","volume":"18","author":"J.D. Londsdale-Eccles","year":"2002","unstructured":"Londsdale-Eccles JD, Grab DJ (2002) Trypanosome hydrolases and the blood-brain barrier. Trends Parasit 18:17\u201319","journal-title":"Trends Parasit"},{"key":"19_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1128\/EC.2.1.84-94.2003","volume":"2","author":"M. Lorger","year":"2003","unstructured":"Lorger M, Engstler M, Homann M, G\u00f6ringer HU (2003) Targeting the variable surface of African trypanosomes using VSG-specific, serum-stable RNA aptamers. Eukaryotic Cell 2:84\u201394","journal-title":"Eukaryotic Cell"},{"key":"19_CR41","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1172\/JCI11459","volume":"106","author":"M.J. Mann","year":"2000","unstructured":"Mann MJ, Dzau VJ (2000) Therapeutic applications of transcription factor decoy oligonucleotides. J Clin Invest 106:1071\u20131075","journal-title":"J Clin Invest"},{"key":"19_CR42","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/j.1460-2075.1983.tb01565.x","volume":"2","author":"F. Michiels","year":"1983","unstructured":"Michiels F, Matthyssens G, Kronenberger P, Pays E, Dero B, Van Assel S, Darville M, Cravador A, Steinert M, Hamers R (1983) Gene activation and re-expression of a Trypanosoma brucei variant surface glycoprotein. EMBO J 2:1185\u20131192","journal-title":"EMBO J"},{"key":"19_CR43","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1073\/pnas.95.6.2902","volume":"95","author":"K.N. Morris","year":"1998","unstructured":"Morris KN, Jensen KB, Julin CM, Weil M, Gold L (1998) High affinity ligands from in vitro selection: complex targets. Proc Natl Acad Sci USA 95:2902\u20132907","journal-title":"Proc Natl Acad Sci USA"},{"key":"19_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1046\/j.0305-1846.2001.00306.x","volume":"27","author":"C. Mulenga","year":"2001","unstructured":"Mulenga C, Mhlanga JD, Kristensson K, Robertson B (2001) Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model. Neuropathol Appl Neurobiol. 27:77\u201385","journal-title":"Neuropathol Appl Neurobiol"},{"key":"19_CR45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev.med.56.062904.144915","volume":"56","author":"S.M. Nimjee","year":"2005","unstructured":"Nimjee SM, Rusconi CP, Sullenger BA (2005) Aptamers: an emerging class of therapeutics. Annu Rev Med 56:187\u2013188","journal-title":"Annu Rev Med"},{"key":"19_CR46","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1001\/jama.281.4.361","volume":"281","author":"B. Pecoul","year":"1999","unstructured":"Pecoul B, Chirac P, Trouiller P, Pinel J (1999) Access to essential drugs in poor countries: a lost battle? JAMA 281:361\u2013367","journal-title":"JAMA"},{"key":"19_CR47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1126\/science.1857967","volume":"253","author":"W.A. Pieken","year":"1991","unstructured":"Pieken WA, Olsen DB, Benseler F, Aurup H, Eckstein F (1991) Kinetic characterization of ribonuclease-resistant 2\u2032-modified hammerhead ribozymes. Science 253:314\u2013317","journal-title":"Science"},{"key":"19_CR48","first-page":"218","volume":"209","author":"W. Pieken","year":"1997","unstructured":"Pieken W (1997) Efficient process technologies for the preparation of oligonucleotides. Ciba Found Symp 209:218\u2013222","journal-title":"Ciba Found Symp"},{"key":"19_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-8510(98)00002-5","volume":"44","author":"M.R. Reich","year":"1998","unstructured":"Reich MR, Govindaraj R (1998) Dilemmas in drug development for tropical diseases. Experiences with praziquantel. Health Policy 44:1\u201318","journal-title":"Health Policy"},{"key":"19_CR50","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/298676a0","volume":"298","author":"A.C. Rice-Ficht","year":"1982","unstructured":"Rice-Ficht AC, Chen KK, Donelson JE (1982) Point mutations during generation of expression-linked extra copy of trypanosome surface glycoprotein gene. Nature 298:676\u2013679","journal-title":"Nature"},{"key":"19_CR51","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0966-842X(97)01200-6","volume":"6","author":"G. Rudenko","year":"1998","unstructured":"Rudenko G, Cross M, Borst P (1998) Changing the end: antigenic variation orchestrated at the telomeres of African trypanosomes. Trends Microbiol 6:113\u2013116","journal-title":"Trends Microbiol"},{"key":"19_CR52","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/oxfordjournals.bmb.a011692","volume":"54","author":"D.H. Smith","year":"1998","unstructured":"Smith DH, Pepin J, Stich AHR (1998) Human African trypanosomiasis: an emerging public health crisis. Brit Med Bull 54:341\u2013355","journal-title":"Brit Med Bull"},{"key":"19_CR53","doi-asserted-by":"publisher","first-page":"985","DOI":"10.2165\/00003495-200060050-00002","volume":"60","author":"I. Stephenson","year":"2000","unstructured":"Stephenson I, Wiselka M (2000) Drug treatment of tropical parasitic infections: recent achievements and developments. Drugs 60:985\u2013995","journal-title":"Drugs"},{"key":"19_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0169-409X(01)00223-X","volume":"53","author":"S.R. Tonge","year":"2001","unstructured":"Tonge SR, Tighe BJ (2001) Responsive hydrophobically associating polymers: a review of structure and properties. Adv Drug Deliv Rev 53:109\u2013122","journal-title":"Adv Drug Deliv Rev"},{"key":"19_CR55","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1046\/j.1365-3156.2001.00803.x","volume":"6","author":"P. Trouiller","year":"2001","unstructured":"Trouiller P, Torreele E, Olliaro P, White N, Foster S, Wirth D, Pecoul B (2001) Drugs for neglected diseases: a failure of the market and a public health failure? Trop Med Int Health 6:945\u2013951","journal-title":"Trop Med Int Health"},{"key":"19_CR56","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","volume":"249","author":"C. Tuerk","year":"1990","unstructured":"Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505\u2013510","journal-title":"Science"},{"key":"19_CR57","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1590\/S0100-879X2001000300002","volume":"34","author":"H. Ulrich","year":"2001","unstructured":"Ulrich H, Alves MJ, Colli W (2001) RNA and DNA aptamers as potential tools to prevent cell adhesion in disease. Braz J Med Biol Res 34:295\u2013300","journal-title":"Braz J Med Biol Res"},{"key":"19_CR58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/expr.1996.4140","volume":"85","author":"T. Urakawa","year":"1997","unstructured":"Urakawa T, Eshita Y, Majiwa PA (1997) The primary structure of Trypanosoma (Nannomonas) congolense variant surface glycoproteins. Exp Parasit 85:215\u2013224","journal-title":"Exp Parasit"},{"key":"19_CR59","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00001432-199712000-00011","volume":"10","author":"A. Gompel Van","year":"1997","unstructured":"Van Gompel A, Vervoort T (1997) Chemotherapy of leishmaniasis and trypanosomiasis. Curr Opin Infect Dis 10:469\u2013474","journal-title":"Curr Opin Infect Dis"},{"key":"19_CR60","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/oli.1.2000.10.63","volume":"10","author":"S.R. Watson","year":"2000","unstructured":"Watson SR, Chang YF, O\u2019Connell D, Weigand L, Ringquist S, Parma DH (2000) Anti-Lselectin aptamers: binding characteristics, pharmacokinetic parameters, and activity against an intravascular target in vivo. Antisense Nucleic Acid Drug Dev 10:63\u201375","journal-title":"Antisense Nucleic Acid Drug Dev"},{"key":"19_CR61","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1172\/JCI11325","volume":"106","author":"R.R. White","year":"2000","unstructured":"White RR, Sullenger BA, Rusconi CP (2000) Developing aptamers into therapeutics. J Clin Invest 106:929\u2013934","journal-title":"J Clin Invest"},{"key":"19_CR62","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1146\/annurev.biochem.68.1.611","volume":"68","author":"D.S. Wilson","year":"1999","unstructured":"Wilson DS, Szostak JW (1999) In vitro selection of functional nucleic acids. Annu Rev Biochem 68:611\u2013647","journal-title":"Annu Rev Biochem"}],"container-title":["Handbook of Experimental Pharmacology","RNA Towards Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/3-540-27262-3_19.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T15:45:51Z","timestamp":1605627951000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/3-540-27262-3_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["3540272615"],"references-count":62,"URL":"https:\/\/doi.org\/10.1007\/3-540-27262-3_19","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/b138836","asserted-by":"object"}]},"subject":[]}}